COMPASS Pathways plc (CMPS)
USD 3.93
(-6.43%)
USD 3.93
(-6.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -187.58 Million USD | -32.78% |
| 2022 | -141.27 Million USD | 47.6% |
| 2021 | -269.62 Million USD | -41.67% |
| 2020 | -190.32 Million USD | -4809.13% |
| 2019 | -3.87 Million USD | 83.08% |
| 2018 | -22.9 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -196.39 Million USD | 14.78% |
| 2024 Q1 | -230.46 Million USD | -22.86% |
| 2024 Q3 | -174.4 Million USD | 11.2% |
| 2023 Q2 | -115.39 Million USD | 0.16% |
| 2023 FY | -187.58 Million USD | -32.78% |
| 2023 Q3 | -215.5 Million USD | -86.76% |
| 2023 Q4 | -187.58 Million USD | 12.95% |
| 2023 Q1 | -115.57 Million USD | 18.19% |
| 2022 Q3 | -170.82 Million USD | 16.34% |
| 2022 FY | -141.27 Million USD | 47.6% |
| 2022 Q2 | -204.19 Million USD | 15.17% |
| 2022 Q1 | -240.69 Million USD | 10.73% |
| 2022 Q4 | -141.27 Million USD | 17.29% |
| 2021 Q1 | -179.52 Million USD | 5.68% |
| 2021 Q3 | -293.95 Million USD | 7.07% |
| 2021 Q4 | -269.62 Million USD | 8.28% |
| 2021 Q2 | -316.33 Million USD | -76.21% |
| 2021 FY | -269.62 Million USD | -41.67% |
| 2020 Q2 | -67.6 Million USD | -3004.04% |
| 2020 Q1 | 2.32 Million USD | 160.05% |
| 2020 FY | -190.32 Million USD | -4809.13% |
| 2020 Q4 | -190.32 Million USD | 3.14% |
| 2020 Q3 | -196.5 Million USD | -190.66% |
| 2019 FY | -3.87 Million USD | 83.08% |
| 2019 Q4 | -3.87 Million USD | 0.0% |
| 2018 FY | -22.9 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.41 Billion USD | 113.298% |
| Addus HomeCare Corporation | 110.39 Million USD | 269.931% |
| AirSculpt Technologies, Inc. | 89.4 Million USD | 309.816% |
| Amedisys, Inc. | 341.35 Million USD | 154.955% |
| American Oncology Network, Inc. | 99.78 Million USD | 287.99% |
| Astrana Health, Inc. | 27.2 Million USD | 789.484% |
| Aveanna Healthcare Holdings Inc. | 1.45 Billion USD | 112.89% |
| IMAC Holdings, Inc. | -221.51 Thousand USD | -84585.637% |
| biote Corp. | 25.86 Million USD | 825.146% |
| Cryo-Cell International, Inc. | 10.48 Million USD | 1888.262% |
| Cross Country Healthcare, Inc. | -11.82 Million USD | -1486.1% |
| DocGo Inc. | -12.78 Million USD | -1366.791% |
| The Ensign Group, Inc. | 1.36 Billion USD | 113.776% |
| Healthcare Services Group, Inc. | -10.69 Million USD | -1653.979% |
| InnovAge Holding Corp. | 56.08 Million USD | 434.447% |
| Assure Holdings Corp. | 14.68 Million USD | 1377.673% |
| The Joint Corp. | -2.47 Million USD | -7465.68% |
| LifeStance Health Group, Inc. | 432.21 Million USD | 143.401% |
| Mobile-health Network Solutions Class A Ordinary Shares | -6.05 Million USD | -3000.34% |
| ModivCare Inc. | 1.13 Billion USD | 116.494% |
| NewGenIvf Group Limited | 278.44 Thousand USD | 67468.89% |
| Novo Integrated Sciences, Inc. | 4.05 Million USD | 4725.719% |
| Option Care Health, Inc. | 822.56 Million USD | 122.805% |
| P3 Health Partners Inc. | 83.7 Million USD | 324.101% |
| P3 Health Partners Inc. | 83.7 Million USD | 324.101% |
| The Pennant Group, Inc. | 323.57 Million USD | 157.974% |
| Surgery Partners, Inc. | 2.86 Billion USD | 106.546% |
| Syra Health Corp. Class A Common Stock | -3.03 Million USD | -6086.996% |
| Talkspace, Inc. | -123.9 Million USD | -51.393% |
| Talkspace, Inc. | -123.9 Million USD | -51.393% |
| The Oncology Institute, Inc. | 86.32 Million USD | 317.299% |
| The Oncology Institute, Inc. | 86.32 Million USD | 317.299% |